Clinical Trials

2 studies in Eosinophilia and Mastocytosis

1. Use of Tamoxifen in Systemic Mastocytosis Rochester, MN View Summary
   Close

   Use of Tamoxifen in Systemic Mastocytosis

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   Not desired

   NCT ID:

   NCT01334996

   IRB Number:

   2506-04

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Rochester: Joseph H Butterfield, MD 507-284-3783
                       
   
   
   

2. Relationship between mastocytosis and neuropsychiatric symptoms. Rochester, MN View Summary
   Close

   Relationship between mastocytosis and neuropsychiatric symptoms.

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   Patients with mastocytosis commonly report neuropsychiatric symptoms (e.g. brain fog, headache, sleep disturbances, etc). However, it is not known whether these symptoms are related to mast cell activity in the blood, or the brain.
   In this study, we will measure mast cell activity in both the blood and the spinal fluid to determine how these measurements relate to neuropsychiatric symptoms.
   

   IRB Number:

   11-000786

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Jonathan H. Smith, M.D. 200 1st Street SW Rochester, MN 55905 Telephone: 507-284-3358 Fax: 507-266-4752